{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:48:58Z","timestamp":1788515338402,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11307-023-01845-2","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T14:28:30Z","timestamp":1692800910000},"page":"944-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Optimization of an Allysine-Targeted PET Probe for Quantifying Fibrogenesis in a Mouse Model of Pulmonary Fibrosis"],"prefix":"10.1007","volume":"25","author":[{"given":"Sergey","family":"Shuvaev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Knipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Rotile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah P.","family":"Weigand-Whittier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris Yuwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jesse D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida P.","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3179-6537","authenticated-orcid":false,"given":"Peter","family":"Caravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"1845_CR1","first-page":"797","volume":"379","author":"DJ Lederer","year":"2018","unstructured":"Lederer DJ, Martinez FJ (2018) Idiopathic pulmonary fibrosis. N Engl J Med 379:797\u2013798","journal-title":"N Engl J Med"},{"key":"1845_CR2","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071\u20132082","journal-title":"N Engl J Med"},{"key":"1845_CR3","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:2083\u20132092","journal-title":"N Engl J Med"},{"key":"1845_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE Jr (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431\u2013440","journal-title":"Am J Respir Crit Care Med"},{"key":"1845_CR5","doi-asserted-by":"publisher","first-page":"680997","DOI":"10.3389\/fmed.2021.680997","volume":"8","author":"WS Bowman","year":"2021","unstructured":"Bowman WS, Echt GA, Oldham JM (2021) Biomarkers in progressive fibrosing interstitial lung disease: optimizing diagnosis, prognosis, and treatment response. Front Med (Lausanne) 8:680997","journal-title":"Front Med (Lausanne)"},{"key":"1845_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI122132","volume":"129","author":"SB Montesi","year":"2019","unstructured":"Montesi SB, Desogere P, Fuchs BC, Caravan P (2019) Molecular imaging of fibrosis: recent advances and future directions. J Clin Invest 129:24\u201333","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"1845_CR7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/IJG.0000000000000910","volume":"27","author":"F Rodriguez-Pascual","year":"2018","unstructured":"Rodriguez-Pascual F, Rosell-Garcia T (2018) Lysyl oxidases: functions and disorders. J Glaucoma 27(Suppl 1):S15\u2013S19","journal-title":"J Glaucoma"},{"key":"1845_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/1061186X.2018.1550649","volume":"27","author":"L Chen","year":"2019","unstructured":"Chen L, Li S, Li W (2019) LOX\/LOXL in pulmonary fibrosis: potential therapeutic targets. J Drug Target 27:790\u2013796","journal-title":"J Drug Target"},{"key":"1845_CR9","doi-asserted-by":"crossref","unstructured":"Chen HH, Waghorn PA, Wei L et al (2017) Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight 2(11):e91506","DOI":"10.1172\/jci.insight.91506"},{"key":"1845_CR10","doi-asserted-by":"publisher","first-page":"eabq6297","DOI":"10.1126\/scitranslmed.abq6297","volume":"14","author":"Y Ning","year":"2022","unstructured":"Ning Y, Zhou IY, Roberts JD Jr et al (2022) Molecular MRI quantification of extracellular aldehyde pairs for early detection of liver fibrogenesis and response to treatment. Sci Transl Med 14:eabq6297","journal-title":"Sci Transl Med"},{"key":"1845_CR11","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1113\/JP280389","volume":"598","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Physiol 598:3793\u20133801","journal-title":"J Physiol"},{"key":"1845_CR12","doi-asserted-by":"publisher","first-page":"L204","DOI":"10.1152\/ajplung.00158.2021","volume":"322","author":"Y Zhong","year":"2022","unstructured":"Zhong Y, Mahoney RC, Khatun Z et al (2022) Lysyl oxidase regulation and protein aldehydes in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol 322:L204\u2013L223","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1845_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nm1685","volume":"14","author":"AM Tager","year":"2008","unstructured":"Tager AM, LaCamera P, Shea BS et al (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14:45\u201354","journal-title":"Nat Med"},{"key":"1845_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jchromb.2017.08.032","volume":"1064","author":"PA Waghorn","year":"2017","unstructured":"Waghorn PA, Oliveira BL, Jones CM, Tager AM, Caravan P (2017) High sensitivity HPLC method for determination of the allysine concentration in tissue by use of a naphthol derivative. J Chromatogr B Analyt Technol Biomed Life Sci 1064:7\u201313","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1845_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/resp.14231","volume":"27","author":"KK Brown","year":"2022","unstructured":"Brown KK, Inoue Y, Flaherty KR et al (2022) Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases. Respirology 27:294\u2013300","journal-title":"Respirology"},{"key":"1845_CR16","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1021\/jacs.8b12342","volume":"141","author":"J Wahsner","year":"2019","unstructured":"Wahsner J, Desogere P, Abston E et al (2019) (68)Ga-NODAGA-Indole: an allysine-reactive positron emission tomography probe for molecular imaging of pulmonary fibrogenesis. J Am Chem Soc 141:5593\u20135596","journal-title":"J Am Chem Soc"},{"issue":"2","key":"1845_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","volume":"207","author":"P Yang","year":"2022","unstructured":"Yang P, Fang Q, Fu Z et al (2022) Comprehensive analysis of fibroblast activation protein (FAP) expression in interstitial lung diseases (ILDs). Am J Respir Crit Care Med 207(2):160\u2013172","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1845_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1164\/rccm.202208-1638ED","volume":"207","author":"SB Montesi","year":"2022","unstructured":"Montesi SB, Horowitz JC (2022) Fibroblast activating protein: skimming the surface of molecular imaging to assess fibrotic disease activity. Am J Respir Crit Care Med 207(2):122\u2013124","journal-title":"Am J Respir Crit Care Med"},{"key":"1845_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1164\/rccm.201903-0503LE","volume":"200","author":"SB Montesi","year":"2019","unstructured":"Montesi SB, Izquierdo-Garcia D, Desogere P et al (2019) Type I collagen-targeted positron emission tomography imaging in idiopathic pulmonary fibrosis: first-in-human studies. Am J Respir Crit Care Med 200:258\u2013261","journal-title":"Am J Respir Crit Care Med"},{"key":"1845_CR20","doi-asserted-by":"crossref","unstructured":"D\u00e9sog\u00e8re P, Tapias LF, Hariri LP et al (2017) Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci Transl Med 9(384):eaaf4696","DOI":"10.1126\/scitranslmed.aaf4696"},{"key":"1845_CR21","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2967\/jnumed.117.193532","volume":"58","author":"P Desogere","year":"2017","unstructured":"D\u00e9sog\u00e8re P, Tapias LF, Rietz TA et al (2017) Optimization of a collagen-targeted PET probe for molecular imaging of pulmonary fibrosis. J Nucl Med 58:1991\u20131996","journal-title":"J Nucl Med"},{"key":"1845_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1164\/rccm.202004-1132OC","volume":"203","author":"SL Brody","year":"2021","unstructured":"Brody SL, Gunsten SP, Luehmann HP et al (2021) Chemokine receptor 2-targeted molecular imaging in pulmonary fibrosis. A clinical trial. Am J Respir Crit Care Med 203:78\u201389","journal-title":"Am J Respir Crit Care Med"},{"key":"1845_CR23","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.chest.2020.08.2043","volume":"159","author":"T Derlin","year":"2021","unstructured":"Derlin T, Jaeger B, Jonigk D et al (2021) Clinical molecular imaging of pulmonary CXCR4 expression to predict outcome of pirfenidone treatment in idiopathic pulmonary fibrosis. Chest 159:1094\u20131106","journal-title":"Chest"},{"key":"1845_CR24","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1038\/s41467-019-11863-w","volume":"10","author":"RH Kimura","year":"2019","unstructured":"Kimura RH, Wang L, Shen B et al (2019) Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nat Commun 10:4673","journal-title":"Nat Commun"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01845-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T16:16:40Z","timestamp":1698164200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01845-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01845-2","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and procedures were performed in accordance with the National Institutes of Health\u2019s \u201cGuide for the Care and Use of Laboratory Animals\u201d and were approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Financial interests: S.S., Y.N., and P.C. are inventors on a patent application that covers the compounds in this report. P.C. has equity in Reveal Pharmaceuticals and Collagen Medical and received consulting income from Collagen Medical. P.C. has received research funding from Janssen, Takeda, Pliant Therapeutics, and Transcode Therapeutics. All others authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}